川崎病初期冠状动脉正常者随访超声复查正常的关联研究
该回顾性研究纳入1995至2014年两家学术儿科转诊机构的464例川崎病患者,评估基线及2周冠状动脉Z评分均正常者6周时出现新异常的比例。结果显示98.3%的患者6周Z评分仍正常,仅1.7%出现新异常,提示无并发症且早期Z评分低于2.0者6周超声可能不必要。
要点
- 基线及2周冠状动脉Z评分均正常的川崎病患者,6周时98.3%仍正常。
- 仅1.7%出现新异常,其中Z评分≥3.0者占0.4%(95%CI 0.1%-1.5%)。
- 无并发症且早期Z评分低于2.0者,6周超声复查可能不必要。
核心结论
- 基线及2周冠状动脉Z评分均正常的川崎病患者,6周时新发冠状动脉异常罕见,提示6周超声复查可能不必要。
研究设计与样本
- 回顾性综述,纳入1995至2014年两家学术儿科转诊机构中接受静脉注射免疫球蛋白治疗的川崎病患者。
- 纳入标准包括无显著先天性心脏病、基线和2周及6周有左右冠状动脉超声测量、且基线和2周最大Z评分低于2.0且无远端动脉瘤。
- 共纳入464例患者,中位年龄3.3岁(四分位距1.8-5.4岁),男性264例(56.9%)。
主要发现
- 6周时456例(98.3%)基线及2周Z评分正常者仍保持正常。
- 剩余8例(1.7%)中,6周内最大Z评分2.0-2.4者5例(1.2%),2.5-2.9者1例(0.2%),3.0及以上者2例(0.4%[95%CI 0.1%-1.5%])。
- 除1例6周时轻度扩张(右冠状动脉Z评分2.1)外,其余患者冠状动脉尺寸最终均正常化。
- 敏感性分析采用较宽松切点(如最大Z评分<2.5)或较宽松时间窗(如21天内超声数据不全者),结果相似,454至463例(98%-99.7%)6周时Z评分低于2.5。
关键数值与推荐
- 冠状动脉正常定义为最大Z评分低于2.0且无远端动脉瘤。
- 主要结局为6周时右冠状动脉或左前降支Z评分≥2.0的患者数。
- 美国心脏协会指南推荐川崎病在基线、治疗后1-2周和4-6周行超声心动图检查。
临床怎么用
- 对于无并发症且基线和2周冠状动脉Z评分均低于2.0的川崎病患者,6周超声心动图复查可能不必要。
- 可减少不必要的超声检查及年幼儿童镇静的需求和风险。
局限性
- 本研究为回顾性综述,仅纳入两家学术儿科转诊机构的患者。
- 部分患者超声数据不完整,敏感性分析中采用较宽松时间窗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: American Heart Association guidelines recommend echocardiography in Kawasaki disease at baseline, 1 to 2 weeks, and 4 to 6 weeks after treatment to detect coronary artery abnormalities. However, these examinations are expensive and may require sedation in young children, which is burdensome and carries some risk. OBJECTIVE: To assess the benefit of additional echocardiographic imaging at 6 weeks in patients with uncomplicated Kawasaki disease who had previously normal coronary arteries. DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective review of patients with Kawasaki disease who were cared for between 1995 and 2014 in 2 academic pediatric referral practices Eligibility criteria included receiving intravenous immunoglobulin treatment for acute Kawasaki disease at a center; the absence of significant congenital heart disease; available echocardiographic measurements of both the right and left anterior descending coronary arteries at 10 days or less after diagnosis (baseline), 2 (±1) weeks, and 6 (±3) weeks of illness; and normal coronary arteries at baseline and 2 weeks, defined as maximum coronary artery z scores less than 2.0 and no distal aneurysms. Data analysis was completed from March 2015 to November 2015. MAIN OUTCOMES AND MEASURES: The number of patients with right coronary artery or left anterior descending coronary artery z scores of 2.0 or more at 6 weeks. RESULTS: The median age of the 464 included patients was 3.3 years (interquartile range, 1.8-5.4 years); 264 (56.9%) were male, 351 of 414 for whom data were available (84.8%) had complete Kawasaki disease, and 66 (14.2%) received additional intravenous immunoglobulin treatment. At 6 weeks of illness, 456 patients (98.3%) who had had normal coronary artery z scores at baseline and 2 weeks continued to have normal z scores. Of the remaining 8 patients (1.7%), the maximum z score within 6 weeks was 2.0 to 2.4 in 5 patients (1.2%), 2.5 to 2.9 in 1 patient (0.2%), and 3.0 or more in 2 patients (0.4% [95% CI, 0.1%-1.5%]). Coronary artery dimensions ultimately normalized in all but 1 patient, who had minimal dilation at 6 weeks (right coronary artery z score, 2.1). Sensitivity analyses using less restrictive cut points (eg, a maximum z score <2.5) or less restrictive timing windows (eg, considering patients with incomplete echocardiographic data within 21 days) gave similar results; in these analyses, 454 to 463 of 464 patients (98% to 99.7%) had coronary artery z scores of less than 2.5 at 6 weeks. CONCLUSIONS AND RELEVANCE: New abnormalities in coronary arteries are rarely detected at 6 weeks in patients with Kawasaki disease who have normal measurements at baseline and 2 weeks of illness, suggesting that the 6-week echocardiographic imaging may be unnecessary in patients with uncomplicated Kawasaki disease and z scores less than 2.0 in the first 2 weeks of illness.
引用
- de Ferranti SD, Gauvreau K, Friedman KG, et al. Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease. JAMA Pediatr. 2018. PMID: 30285057. doi:10.1001/jamapediatrics.2018.3310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。